Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices.

This study assessed the total costs of testing, including the estimated costs of delaying care, associated with next-generation sequencing (NGS) versus single-gene testing strategies among patients with newly diagnosed metastatic non-small cell lung cancer (mNSCLC) from a Canadian public payer persp...

Descripción completa

Detalles Bibliográficos

Publicado en:	Current Oncology Vol. 30; no. 2; pp. 2348 - 2366
Autores principales:	Sheffield, Brandon S., Eaton, Kiefer, Emond, Bruno, Lafeuille, Marie-Hélène, Hilts, Annalise, Lefebvre, Patrick, Morrison, Laura, Stevens, Andrea L., Ewara, Emmanuel M., Cheema, Parneet
Formato:	Journal Article
Publicado:	MDPI Feb2023
Acceso en línea:	Ver este registro en EBSCOhost